A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/29/2011	US20110319474 siRNA targeting cyclin-dependent kinase 4 (CDK4)
12/29/2011	US20110319473 Compositions and methods for enhancement of nucleic acid delivery
12/29/2011	US20110319472 Methods of prognosticating and treating ewing sarcoma/pnet and other neoplasms
12/29/2011	US20110319471 Lna antagonists targeting the androgen receptor
12/29/2011	US20110319470 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
12/29/2011	US20110319469 SNPs of Apolipoprotein B and Modulation of Their Expression
12/29/2011	US20110319468 Cyclic amine compounds
12/29/2011	US20110319467 Absorption Enhancement of Statins and Omega Fatty Acids
12/29/2011	US20110319466 Method and composition for treating heart failure
12/29/2011	US20110319465 Estrogen receptor modulators and uses thereof
12/29/2011	US20110319464 Methods for treating benign prostatic hyperplasia
12/29/2011	US20110319463 Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
12/29/2011	US20110319461 Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
12/29/2011	US20110319460 Kinase inhibitors
12/29/2011	US20110319459 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
12/29/2011	US20110319458 Compound with agitation effect on peroxisome proliferator-activated receptor. process for its preparation and use thereof
12/29/2011	US20110319457 Deferacirox dispersible tablets
12/29/2011	US20110319456 Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same
12/29/2011	US20110319455 Antifungal Treatment
12/29/2011	US20110319454 Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
12/29/2011	US20110319453 Methods of Administering Pirfenidone Therapy
12/29/2011	US20110319452 Cyano anthranilamide insecticides
12/29/2011	US20110319451 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders
12/29/2011	US20110319450 Benzimidazole compound crystal
12/29/2011	US20110319449 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
12/29/2011	US20110319448 Guanidine-containing compounds useful as muscarinic receptor antagonists
12/29/2011	US20110319447 Triazole compounds that modulate hsp90 activity
12/29/2011	US20110319446 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
12/29/2011	US20110319445 Heteroaryl antagonists of prostaglandin d2 receptors
12/29/2011	US20110319444 Quinuclidine carbonate salts and medicinal composition thereof
12/29/2011	US20110319443 Inhibitors of akt activity
12/29/2011	US20110319442 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
12/29/2011	US20110319441 Manufacture of variable density dosage forms utilizing radiofrequency energy
12/29/2011	US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
12/29/2011	US20110319439 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
12/29/2011	US20110319438 Novel sulfonamides as l-cpt1 inhibitors
12/29/2011	US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity
12/29/2011	US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof
12/29/2011	US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
12/29/2011	US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
12/29/2011	US20110319429 Substituted 1,1,3,1-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/29/2011	US20110319427 Use of 5ahq and bortezomib for the treatment of hematological diseases
12/29/2011	US20110319426 Substituted Isoindoles
12/29/2011	US20110319425 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
12/29/2011	US20110319424 Naphthyridin-2(1h) -one compounds useful as antibacterials
12/29/2011	US20110319423 Novel dopamine d3 receptor ligands and preparation and medical uses of the same
12/29/2011	US20110319422 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
12/29/2011	US20110319421 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
12/29/2011	US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
12/29/2011	US20110319419 Methotrexate Adjuvants to Reduce Toxicity and Methods for Using the Same
12/29/2011	US20110319418 Prokineticin 1 receptor antagonists for the treatment of pain
12/29/2011	US20110319417 Methods and compositions for treating anxiety
12/29/2011	US20110319416 Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
12/29/2011	US20110319415 Susceptibility to HSP90-Inhibitors
12/29/2011	US20110319414 Novel triazine derivative and pharmaceutical composition comprising the same
12/29/2011	US20110319413 Piperazine compound capable of inhibiting prostaglandin d synthase
12/29/2011	US20110319412 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
12/29/2011	US20110319411 Isoindolinone and related analogs as sirtuin modulators
12/29/2011	US20110319410 Pyrazine derivatives and use as pi3k inhibitors
12/29/2011	US20110319409 7-aza-quinazoline pde10 inhibitors
12/29/2011	US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries
12/29/2011	US20110319407 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof
12/29/2011	US20110319406 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
12/29/2011	US20110319405 Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors
12/29/2011	US20110319404 Method for treating non-hodkin's lymphoma
12/29/2011	US20110319403 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
12/29/2011	US20110319402 Aerosol formulation for the inhalation of beta agonists
12/29/2011	US20110319401 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of xlf-iii-43
12/29/2011	US20110319400 Prokineticin 1 receptor antagonists for the treatment of pain
12/29/2011	US20110319399 External preparation containing analgesic/anti-inflammatory agent
12/29/2011	US20110319398 Inhibition of yops translocation
12/29/2011	US20110319397 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
12/29/2011	US20110319396 Benzodiazepin-2-on derivatives
12/29/2011	US20110319395 Pharmaceutical Formulation of Olanzapine
12/29/2011	US20110319394 Fused heterocyclic compounds
12/29/2011	US20110319393 Anthelmintic agents and their use
12/29/2011	US20110319392 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors
12/29/2011	US20110319391 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
12/29/2011	US20110319390 6-Aminoisoquinoline Compounds
12/29/2011	US20110319389 Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
12/29/2011	US20110319388 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
12/29/2011	US20110319387 Indole derivatives for treating neurodegenerative diseases
12/29/2011	US20110319386 Neurogenesis by muscarinic receptor modulation
12/29/2011	US20110319385 Quinoxaline compound
12/29/2011	US20110319384 Pharmaceutical Compositions
12/29/2011	US20110319383 Extended Release Formulations Comprising Quetiapine and Methods for Their Manufacture
12/29/2011	US20110319382 Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions
12/29/2011	US20110319381 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
12/29/2011	US20110319380 Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof
12/29/2011	US20110319379 Substituted Indazole Amides And Their Use As Glucokinase Activators
12/29/2011	US20110319378 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
12/29/2011	US20110319377 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders
12/29/2011	US20110319376 Methods and apparatus for transdermal or transmucosal application of testosterone
12/29/2011	US20110319375 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders
12/29/2011	US20110319374 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders
12/29/2011	US20110319373 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders
12/29/2011	US20110319372 Method of diagnosing and therapeutically treating a patient for a traumatic brain injury
12/29/2011	US20110319371 Pharmaceutical formulations comprising 4-hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
12/29/2011	US20110319370 Combination Hormone Therapy for the Eye
12/29/2011	US20110319369 Combination of a 17 alpha-hydroxylase/c17, 20-lyase inhibitor with an additional therapeutic agent

1 ... 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 ... 7860